“…However such anesthesia has not received rapid development due to complexity, high cost of obtaining gas and its large consumption during anesthesia. In the late 80s -early 90s in connection with the improvement of anesthesia and respiratory devices, the advent of high-quality gas analyzers and a wave of renewed interest in low flowed anesthesia has resumed interest in xenon [1,2]. Being tolerant NMDA-receptor antagonist, it also has an impact on the GABA-receptors or not NMDA-glutamate ergo receptors, and kaynat receptors [3].…”